Skip to main content

Table 1 Baseline patients’ characteristics

From: Clinical significance of precedent asymptomatic non-sustained ventricular tachycardias on subsequent ICD interventions and heart failure hospitalization in primary prevention ICD patients

 Total (N = 157)NSVT (+) (N = 51)NSVT (−) (N = 106)P value
Age (years)66.0 ± 12.165.7 ± 11.466.2 ± 12.50.80
Male135 (86%)45 (88%)90 (85%)0.57
NYHA
 Class I21 (13%)8 (16%)13 (12%)0.62
 Class II105 (67%)35 (68%)70 (66%)
 Class III31 (20%)8 (16%)23 (22%)
VVI-ICD76 (48%)24 (47%)52 (49%)0.79
VDD/DDD-ICD31 (20%)9 (18%)22 (21%)
CRT-D50 (32%)18 (35%)32 (30%)
Hypertension113 (72%)39 (76%)74 (70%)0.38
Diabetes mellitus48 (31%)18 (35%)30 (28%)0.37
Serum creatinine1.29 ± 0.781.16 ± 0.311.35 ± 0.920.17
Hemoglobin (g/dL)13.8 ± 1.814.0 ± 1.613.8 ± 1.80.53
Atrial fibrillation60 (38%)16 (31%)44 (42%)0.22
Ischemic cardiomyopathy96 (61%)38 (75%)58 (55%)0.017
LVEF (%)31.5 ± 9.132.5 ± 10.431.1 ± 8.40.38
β Blocker150 (96%)49 (96%)101 (95%)0.82
ACEi or ARB146 (93%)47 (92%)99 (93%)0.78
  1. ACEi angiotensin-converting-enzyme inhibitor, ARB angiotensin II receptor blocker, LVEF left ventricular ejection fraction, NYHA New York Heart Association